KOAN
Resonate Blends, Inc.
Price Chart
Latest Quote
$0.00
-0.00 (-12.50%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 3,250,717 |
Stock Information
| Shares Outstanding | 346.31M |
| Total Debt | $4.16M |
| Cash Equivalents | $18K |
| Revenue | $2.23M |
| Net Income | $1.14M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $242K |
| EPS (TTM) | $-0.01 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.33M |
| Sales | $2.23M |
| Income | $1.14M |
| Book/sh | $-0.02 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.22 |
Returns & Margins
| ROA | -28.22% |
| Gross Margin | 65.52% |
| Operating Margin | -76.66% |
| Profit Margin | 51.23% |
Ownership
| Insider Ownership | 1.50% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.11 |
| P/B | -0.03 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 55.56 |
| ATR | 0.0002 |
| Shares Float | 191.77M |
| Volatility | 3.51 |
| Rel Volume | 1.39 |
Performance History
| Week | +25.00% |
| Month | -9.09% |
| Quarter | -33.33% |
| 6 Months | -78.26% |
| YTD | -77.06% |
| Year | -54.55% |
| 3 Years | -97.06% |
| 5 Years | -99.80% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $0.00 | 6,330,783 |
| 2026-06-24 | $0.00 | 6,612,223 |
| 2026-06-23 | $0.00 | 7,924,177 |
| 2026-06-22 | $0.00 | 0 |
| 2026-06-18 | $0.00 | 4,358,994 |
| 2026-06-17 | $0.00 | 5,036,367 |
| 2026-06-16 | $0.00 | 2,050,001 |
| 2026-06-15 | $0.00 | 3,166,183 |
| 2026-06-12 | $0.00 | 1,803,745 |
| 2026-06-11 | $0.00 | 931,183 |
| 2026-06-10 | $0.00 | 8,335,699 |
| 2026-06-09 | $0.00 | 4,299,484 |
| 2026-06-08 | $0.00 | 2,739,407 |
| 2026-06-05 | $0.00 | 0 |
| 2026-06-04 | $0.00 | 2,096,182 |
| 2026-06-03 | $0.00 | 16,833,110 |
| 2026-06-02 | $0.00 | 2,301,822 |
| 2026-06-01 | $0.00 | 7,150,603 |
| 2026-05-29 | $0.00 | 6,608,381 |
| 2026-05-28 | $0.00 | 2,375,720 |
| 2026-05-27 | $0.00 | 2,801,014 |
| 2026-05-26 | $0.00 | 7,261,801 |
About Resonate Blends, Inc.
Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.
đ° Latest News
No news articles available at the moment. Check back later for updates on KOAN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $660,024 | $114,140 | $33,068 | $8,565 |
| Cost Of Revenue | $660,024 | $114,140 | $33,068 | $19,148 |
| Total Revenue | $1,896,215 | $16,468 | $49,501 | $27,031 |
| Operating Revenue | $1,896,215 | $16,468 | $49,501 | $27,031 |
| Expenses | ||||
| Interest Expense | $340,452 | $636,616 | $150,065 | $145,875 |
| Total Expenses | $3,593,841 | $415,691 | $1,438,896 | $2,558,436 |
| Other Income Expense | $-84,884 | $-219,407 | $2,224,882 | $-1,948,691 |
| Other Non Operating Income Expenses | $3,371 | - | $11,355 | $690 |
| Net Non Operating Interest Income Expense | $-350,698 | $-797,349 | $-181,860 | $-392,960 |
| Total Other Finance Cost | $10,246 | $160,733 | $31,795 | $247,085 |
| Interest Expense Non Operating | $340,452 | $636,616 | $150,065 | $145,875 |
| Operating Expense | $2,933,817 | $301,551 | $1,405,828 | $2,539,288 |
| Selling And Marketing Expense | $683,491 | $23,772 | $378,706 | $611,914 |
| General And Administrative Expense | $2,188,451 | $301,551 | $820,660 | $1,522,314 |
| Rent Expense Supplemental | - | - | $10,591 | $3,239 |
| Other Operating Expenses | - | - | $206,462 | $400,349 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Net Interest Income | $-350,698 | $-797,349 | $-181,860 | $-392,960 |
| Normalized Income | $-2,044,953 | $-1,196,572 | $-1,095,059 | $-2,923,675 |
| Net Income From Continuing And Discontinued Operation | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Total Operating Income As Reported | $-1,697,626 | $-399,223 | $-1,389,395 | $-2,531,405 |
| Net Income Common Stockholders | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Net Income | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Net Income Including Noncontrolling Interests | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Net Income Continuous Operations | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Pretax Income | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Special Income Charges | $-17,455 | $-5,033 | $0 | $62,500 |
| Operating Income | $-1,697,626 | $-399,223 | $-1,389,395 | $-2,531,405 |
| Gross Profit | $1,236,191 | $-97,672 | $16,433 | $7,883 |
| Earnings From Equity Interest | - | - | $0 | $0 |
| Depreciation Amortization Depletion Income Statement | - | - | $7,738 | $4,711 |
| Depreciation And Amortization In Income Statement | - | - | $7,738 | $4,711 |
| Net Income Discontinuous Operations | - | - | - | $0 |
| Depreciation Income Statement | - | - | - | $4,711 |
| Per Share | ||||
| Diluted EPS | $-0.02 | $-0.02 | $0.01 | $-0.16 |
| Basic EPS | $-0.02 | $-0.02 | $0.01 | $-0.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $464,841 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,687,365 | $-551,149 | $-1,402,097 | $-2,762,506 |
| Total Unusual Items | $-88,255 | $-219,407 | $2,213,527 | $-1,949,381 |
| Total Unusual Items Excluding Goodwill | $-88,255 | $-219,407 | $2,213,527 | $-1,949,381 |
| Reconciled Depreciation | $17,136 | $8,807 | $7,738 | $15,294 |
| EBITDA (Bullshit earnings) | $-1,775,620 | $-770,556 | $811,430 | $-4,711,887 |
| EBIT | $-1,792,756 | $-779,363 | $803,692 | $-4,727,181 |
| Diluted Average Shares | $98,093,448 | $80,013,557 | $75,437,604 | $31,085,610 |
| Basic Average Shares | $98,093,448 | $80,013,557 | $75,437,604 | $31,085,610 |
| Diluted NI Availto Com Stockholders | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Gain On Sale Of Business | $15,000 | $0 | - | - |
| Other Special Charges | $32,455 | $5,033 | $-1,223 | $-62,500 |
| Gain On Sale Of Security | $-70,800 | $-214,374 | $2,213,527 | $-2,011,881 |
| Research And Development | $61,875 | $0 | - | - |
| Selling General And Administration | $2,871,942 | $301,551 | $1,199,366 | $2,134,228 |
| Other Gand A | $2,188,451 | $301,551 | $386,535 | $725,960 |
| Salaries And Wages | - | $28,750 | $434,125 | $793,115 |
| Impairment Of Capital Assets | - | - | $0 | $0 |
| Rent And Landing Fees | - | - | $10,591 | $3,239 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,199,579 | $-2,135,572 | $-1,146,730 | $-4,101,931 |
| Total Assets | $1,854,461 | $992,341 | $399,121 | $300,956 |
| Total Non Current Assets | $820,682 | $15,403 | $24,210 | $31,437 |
| Current Assets | $1,033,779 | $976,938 | $374,911 | $269,519 |
| Prepaid Assets | $970,000 | $970,000 | $0 | $10,830 |
| Receivables | $55,731 | $0 | $150,000 | $0 |
| Loans Receivable | $6,000 | $0 | - | - |
| Accounts Receivable | $49,731 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $8,048 | $6,938 | $64,419 | $12,913 |
| Cash And Cash Equivalents | $8,048 | $6,938 | $64,419 | $12,913 |
| Inventory | - | $0 | $160,492 | $245,776 |
| Cash Financial | - | $6,938 | $64,419 | $12,913 |
| Financial Assets | - | - | $0 | $0 |
| Other Receivables | - | - | $150,000 | - |
| Other Current Assets | - | - | - | $-1 |
| Debt | ||||
| Net Debt | $3,849,464 | $2,508,895 | $924,381 | $1,852,087 |
| Total Debt | $3,857,512 | $2,515,833 | $988,800 | $1,865,000 |
| Current Debt And Capital Lease Obligation | $3,857,512 | $2,515,833 | $988,800 | $1,865,000 |
| Current Debt | $3,857,512 | $2,515,833 | $988,800 | $1,865,000 |
| Other Current Borrowings | $2,531,069 | $1,915,833 | $988,800 | $1,865,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,054,040 | $3,127,913 | $1,545,851 | $4,402,887 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $5,054,040 | $3,127,913 | $1,545,851 | $4,402,887 |
| Current Notes Payable | $1,326,443 | $600,000 | $0 | $45,000 |
| Payables And Accrued Expenses | $1,196,528 | $445,219 | $484,564 | $251,873 |
| Payables | $1,196,528 | $445,219 | $484,564 | $251,873 |
| Accounts Payable | $1,196,528 | $445,219 | $319,618 | $206,873 |
| Other Current Liabilities | - | $166,861 | $72,487 | $2,286,014 |
| Equity | ||||
| Common Stock Equity | $-3,199,779 | $-2,135,772 | $-1,146,930 | $-4,102,131 |
| Preferred Stock Equity | $200 | $200 | $200 | $200 |
| Total Equity Gross Minority Interest | $-3,199,579 | $-2,135,572 | $-1,146,730 | $-4,101,931 |
| Stockholders Equity | $-3,199,579 | $-2,135,572 | $-1,146,730 | $-4,101,931 |
| Other Equity Interest | $-261,059 | $-261,059 | $-261,059 | - |
| Retained Earnings | $-28,869,611 | $-26,736,403 | $-25,320,424 | $-25,974,051 |
| Long Term Equity Investment | - | - | $100 | $100 |
| Other | ||||
| Ordinary Shares Number | $110,401,280 | $86,623,596 | $75,437,604 | $45,046,637 |
| Share Issued | $110,401,280 | $86,623,596 | $75,437,604 | $45,046,637 |
| Tangible Book Value | $-3,199,779 | $-2,135,772 | $-1,146,930 | $-4,102,131 |
| Invested Capital | $657,733 | $380,061 | $-158,130 | $-2,237,131 |
| Working Capital | $-4,020,261 | $-2,150,975 | $-1,170,940 | $-4,133,368 |
| Total Capitalization | $-3,199,579 | $-2,135,572 | $-1,146,730 | $-4,101,931 |
| Additional Paid In Capital | $25,498,539 | $24,853,028 | $24,427,009 | $21,867,416 |
| Capital Stock | $432,552 | $8,862 | $7,744 | $4,704 |
| Common Stock | $432,352 | $8,662 | $7,544 | $4,504 |
| Preferred Stock | $200 | $200 | $200 | $200 |
| Investments And Advances | $805,379 | $100 | $100 | $100 |
| Net PPE | $15,303 | $15,303 | $24,110 | $31,337 |
| Dueto Related Parties Current | - | $70,099 | $164,946 | $45,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,029,062 | $11,166 | $-1,428,467 | $-2,818,150 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,029,062 | $11,166 | $-1,428,467 | $-2,782,102 |
| Cash Flow From Continuing Operating Activities | $-1,029,062 | $11,166 | $-1,428,467 | $-2,782,102 |
| Operating Gains Losses | $224,286 | $219,407 | $-2,213,527 | $1,949,381 |
| Cash From Discontinued Operating Activities | - | - | $0 | $0 |
| Investing Activities | ||||
| Investing Cash Flow | $-358,261 | $-805,000 | $0 | $-36,048 |
| Cash Flow From Continuing Investing Activities | $-358,261 | $-805,000 | $0 | $-36,048 |
| Capital Expenditure | - | - | - | $-36,048 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $10,000 | $91,173 | $1,367,115 |
| Financing Cash Flow | $1,388,433 | $736,353 | $1,479,973 | $2,716,738 |
| Cash Flow From Continuing Financing Activities | $1,388,433 | $736,353 | $1,479,973 | $2,716,738 |
| Net Common Stock Issuance | $0 | $10,000 | $91,173 | $1,367,115 |
| Common Stock Issuance | $0 | $10,000 | $91,173 | $1,367,115 |
| Net Other Financing Charges | - | $-94,847 | - | $1,367,115 |
| Other | ||||
| Repayment Of Debt | $-137,640 | $-233,647 | $0 | $-515,377 |
| Issuance Of Debt | $1,526,073 | $930,000 | $1,388,800 | $1,865,000 |
| Interest Paid Supplemental Data | $826 | $0 | $0 | $38,048 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $8,048 | $6,938 | $64,419 | $12,913 |
| Beginning Cash Position | $6,938 | $64,419 | $12,913 | $114,325 |
| Changes In Cash | $1,110 | $-57,481 | $51,506 | $-101,412 |
| Proceeds From Stock Option Exercised | $0 | $30,000 | $0 | - |
| Net Issuance Payments Of Debt | $1,388,433 | $696,353 | $1,388,800 | $1,349,623 |
| Net Short Term Debt Issuance | $1,388,433 | $696,353 | $0 | - |
| Short Term Debt Payments | $-137,640 | $-233,647 | $0 | - |
| Short Term Debt Issuance | $1,526,073 | $930,000 | - | - |
| Net Business Purchase And Sale | $-358,261 | $-805,000 | $0 | - |
| Purchase Of Business | $-358,261 | $-805,000 | $0 | - |
| Change In Working Capital | $745,309 | $646,147 | $178,292 | $-290,212 |
| Change In Payables And Accrued Expense | $751,309 | $455,655 | $232,179 | $-88,205 |
| Change In Inventory | $0 | $160,492 | $85,283 | $-191,177 |
| Change In Receivables | $-6,000 | $30,000 | $-150,000 | $0 |
| Other Non Cash Items | $117,415 | $552,784 | $-54,597 | $16,142 |
| Depreciation Amortization Depletion | $17,136 | $8,807 | $7,738 | $15,294 |
| Depreciation And Amortization | $17,136 | $8,807 | $7,738 | $15,294 |
| Gain Loss On Investment Securities | $155,043 | $214,374 | $-2,213,527 | $1,949,381 |
| Gain Loss On Sale Of Business | $69,243 | $0 | - | - |
| Net Income From Continuing Operations | $-2,133,208 | $-1,415,979 | $653,627 | $-4,873,056 |
| Net Long Term Debt Issuance | - | $930,000 | $1,388,800 | $1,349,623 |
| Long Term Debt Payments | - | $-138,800 | $0 | $-515,377 |
| Long Term Debt Issuance | - | $930,000 | $1,388,800 | $1,865,000 |
| Change In Payable | - | $455,655 | $232,179 | $-88,205 |
| Change In Account Payable | - | $455,655 | $112,233 | $-8,205 |
| Change In Prepaid Assets | - | $0 | $10,830 | $-10,830 |
| Net PPE Purchase And Sale | - | - | $0 | $-36,048 |
| Purchase Of PPE | - | - | $0 | $-36,048 |
| Change In Other Current Liabilities | - | - | $0 | $0 |
| Stock Based Compensation | - | - | $0 | $400,349 |
| Change In Other Working Capital | - | - | - | $4,711 |
| Asset Impairment Charge | - | - | - | $0 |
| Depreciation | - | - | - | $4,711 |
Fetched: 2026-02-02